Occasional Binge Drinking Triples Liver Damage Risk, Study Finds

Experts warn that even 'occasional binge drinking' can triple the risk of liver damage, a finding that challenges common assumptions about alcohol consumption. New research reveals that a single heavy drinking session per month may push individuals into dangerous territory, particularly those with metabolic dysfunction–associated steatotic liver disease (MASLD). This condition, previously known as non-alcoholic fatty liver disease, affects approximately one in three British adults, making it the most prevalent liver disorder in the UK. It develops when fat accumulates in the liver, often without noticeable symptoms, and is linked to factors like obesity, poor diet, and lack of physical activity rather than alcohol intake.

MASLD is not confined to any specific demographic, but certain groups face heightened risks. Overweight individuals with excess abdominal fat, people with type 2 diabetes, those with polycystic ovary syndrome, and adults over 50 are especially vulnerable. The condition can progress silently, only revealing itself through fatigue, unexplained discomfort in the upper right abdomen, or a general sense of unwellness. Despite its prevalence, many remain unaware of their risk, underscoring the need for greater public education.

A groundbreaking study published in *Clinical Gastroenterology and Hepatology* adds urgency to this call. Researchers analyzed data from over 8,000 adults between 2017 and 2023, finding that those who binge drank at least once a month faced nearly three times the risk of advanced liver fibrosis compared to individuals who spread their alcohol consumption evenly. Fibrosis, a precursor to cirrhosis, involves scar tissue forming in the liver, which can lead to life-threatening complications like liver failure or cancer. The study's lead author, Brian P. Lee, a hepatologist and liver transplant specialist, emphasized that the findings represent a "huge wake-up call." He noted that traditional medical assessments often focus solely on total alcohol consumption, not the pattern of drinking, and urged the public to recognize the dangers of occasional heavy drinking even if they otherwise drink moderately.

The research defines binge drinking as consuming four or more drinks in a day for women, or five or more for men, at least once monthly. Surprisingly, over half of the study's participants reported engaging in this behavior, with nearly 16% of those with MASLD falling into this category. Even among individuals with similar age, sex, and weekly alcohol intake, those who binge drank occasionally showed a significantly higher risk of liver damage. Lee stressed that while the study focused on MASLD, its implications may extend to broader populations, given the high prevalence of episodic heavy drinking.

The findings highlight a critical gap in public health messaging. Many people assume that spreading out alcohol consumption reduces harm, but this research challenges that belief. For individuals with MASLD, even a single binge episode could accelerate liver damage, potentially leading to irreversible conditions like cirrhosis. The NHS recommends consulting a GP if MASLD is suspected, as early intervention can prevent progression from the initial stage of fat accumulation to inflammation and fibrosis. However, awareness remains limited, and limited access to information about liver health compounds the risk for vulnerable communities.

As the study underscores, the danger of occasional binge drinking is not confined to heavy drinkers alone. It affects a wide range of individuals, including those who might otherwise consider themselves low-risk. The research calls for a reevaluation of public health strategies, urging healthcare providers and researchers to prioritize education and prevention efforts. For now, the message is clear: even infrequent heavy drinking can have severe consequences, and avoiding such episodes—regardless of overall consumption—may be the safest course of action.